JENNIFER GRADY: Open Payments
NPI 1548889215 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 113 payments from 17 companies in 2025. Trend: 2023 $839 · 2024 $1,851 · 2025 $2,023
Food & beverage: $1,912Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 28 | $392 |
| Neurocrine BioSciences, Inc. | 8 | $339 |
| Otsuka America Pharmaceutical, Inc. | 15 | $204 |
| E.R. Squibb & Sons, L.L.C. | 10 | $175 |
| ABBVIE INC. | 17 | $165 |
| Vanda Pharmaceuticals Inc. | 5 | $141 |
| Lundbeck LLC | 6 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $97 |
| Alkermes, Inc. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
Products named: INGREZZA, REXULTI, AUSTEDO XR, COBENFY, VRAYLAR, FANAPT, CAPLYTA, ARISTADA.
Industry payments across FL — which companies pay providers there.
